20123112_1|20123112|15585|#section_info|0:0|Using this strategy, we measured only those Kir6.2 and SUR2A subunits that physically assemble in sarcolemma to form a channel. Western blot has demonstrated that the level of myocardial SUR2A protein was increased in H9C2 cells in comparison to control cells (Fig. 1). |#main_body|GO:0005102|receptor binding|#go_definition|IPI|GOA|Kcnj8(25472)|#gene_synonym
0.75	20123112_187|20123112|31877|Discussion|0:0|It has been shown that M-LDH, but not H-LDH, physically associates with Kir6.2 and SUR2A subunits and is integral part of the sarcolemmal KATP channel protein complex [9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	20123112_145|20123112|25725|Discussion|0:0|It has been previously shown that moderate increase in SUR2A generates a myocardial phenotype with increased numbers of sarcolemmal KATP channels and increased resistance to ischaemia-reperfusion [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	20123112_160|20123112|27438|Discussion|0:0|The finding that DNP-induced K+ current was increased in cells infected with SUR2A is in accord with these cells having increased number of sarcolemmal KATP channels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	20123112_4|20123112|158|abstract|0:0|Adenoviral SUR2A construct (AV-SUR2A) increased SUR2A expression, number of KATP channels and subsarcolemmal ATP in glycolysis-sensitive manner in H9C2 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	20123112_97|20123112|15521|Results|0:0|Infection with SUR2A increases the level of SUR2A in H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	20123112_18|20123112|2857|Introduction|0:0|It has been shown that rat heart embryonic H9C2 cells are good experimental model to study SUR2A, KATP channels and cardioprotection [6].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_114|20123112|19563|Results|0:0|Infection with SUR2A increases levels of subsarcolemmal ATP in H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_122|20123112|20996|Results|0:0|An increased ATP levels in subsarcolemmal space would be in accord with the idea that enzymes physically associated with the KATP channel subunits produce ATP and that infection with SUR2A increases number of ATP-producing KATP channel protein complexes [4,5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_133|20123112|23276|Results|0:0|We have recently shown that 193glyM-LDH, a mutant form of muscle lactate dehydrogenase (M-LDH) that has lost its catalytic activity while retained the ability to physically interact with Kir6.2/SUR2A, inhibits both DNP-induced KATP channel activation and ATP production by sarcolemmal KATP channels [4].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_144|20123112|25530|Discussion|0:0|In the present study we have shown that SUR2A mediate cardioprotection by increasing the numbers of sarcolemmal KATP channels and consequent increase in K+ current and subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_170|20123112|28837|Discussion|0:0|However, it has been shown that the activation of KATP channels is protective in cells that do not generate action membrane potential, including diastolic cardiomyocytes [14-16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_177|20123112|28837|Discussion|0:0|The structural studies of KATP channels have shown that channel subunits in vivo are physically associated with enzymes that catalyses ATP production, most of them being involved in glycolysis [9,12,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_8|20123112|158|abstract|0:0|We conclude that AV-SUR2A increases resistance to metabolic stress in H9C2 cells by increasing the number of sarcolemmal KATP channels and subsarcolemmal ATP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_11|20123112|1336|Introduction|0:0|Structurally, sarcolemmal KATP channels in vivo are composed of an inward rectifier, Kir6.2 and Kir6.1, SUR2A, an ATP-binding protein, and accessory proteins that are glycolytic and ATP-producing enzymes [reviewed in 1].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_12|20123112|1336|Introduction|0:0|Recently, it has been shown that cardiomyocytes from transgenic mice overexpressing KATP channel regulatory subunit, SUR2A, acquire resistance against hypoxia and other types of metabolic stresses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_147|20123112|25725|Discussion|0:0|Under CMV promoter SUR2A mRNA in hearts of transgenic animals was increased for ~ 6 times in comparison to the wild type [2], which is similar to those in H9C2 cells achieved by AV-SUR2A.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_172|20123112|28837|Discussion|0:0|Specifically, it has been found that inhibition of the catalytic activity of M-LDH, an enzyme physically associated with sarcolemmal KATP channels [9], results in decreased ATP levels as well as inhibited KATP channels-mediated K+ current in response to stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_203|20123112|31877|Discussion|0:0|The fact that 193glyM-LDH was more efficient in inhibiting SUR2A than Kir6.2AFA supports our hypothesis that infection of H9C2 cells with AV-SUR2A led to increased numbers of sarcolemmal KATP channels, increase in subsarcolemmal ATP and increased K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20123112_165|20123112|27438|Discussion|0:0|Here, we have shown that an acute increase in SUR2A expression confers cytoprotection, which would be in accord with reports associating increased SUR2A with the cardioprotective outcome [29].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20123112_208|20123112|36288|Discussion|0:0|The mechanism underlying SUR2A-mediated cytoprotection is associated with increase in number of sarcolemmal KATP channels, increased K+ current as well as increased production of ATP by the glycolytic enzymes physically associated with KATP channel subunits.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_148|20123112|25725|Discussion|0:0|This modest up-regulation of SUR2A has resulted in increased number of sarcolemmal KATP channels, which is in accord to what has been observed in transgenic CMV-SUR2A phenotype [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_181|20123112|28837|Discussion|0:0|This would be in agreement with the idea that ATP produced by glycolytic enzymes physically associated with KATP channel subunits underlies SUR2A-mediated increase in subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_195|20123112|31877|Discussion|0:0|This finding is in accord with our hypothesis that infection with AV-SUR2A has increased the number of sarcolemmal KATP channel protein complexes that are both important for subsarcolemmal ATP levels and K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_197|20123112|31877|Discussion|0:0|However, it is known that ischaemia opens sarcolemmal KATP channels before the fall of intracellular ATP occur [38], suggesting that the intracellular level of ATP is not the only factor that regulates the channel activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_214|20123112|36946|Discussion|0:0|M-LDH physically associated with sarcolemmal KATP channels mediates cytoprotection in heart embryonic H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_15|20123112|1336|Introduction|0:0|More specifically, it has been suggested that enzymes that are physically associated with KATP channel subunits regulate subsarcolemmal/intracellular ATP levels, which, in turn, promotes cellular survival under metabolic stress [3-5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_26|20123112|3734|Methods|0:0|For the experiments H9C2 cells were infected with adenoviral constructs containing either green fluorescent protein (GFP, gift from C. Sunderland, University of Dundee; cells infected with GFP have served as control cells in this study), gly193-M-LDH (a catalytically inactive mutant of M-LDH, [9], Kir6.2, or Kir6.2AFA (a mutant form of Kir6.2 where the pore GFG was mutated into AFA leading to largely reduced K+ conductance, [10]).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_103|20123112|16656|Results|0:0|In control cells, exposure to DNP (10 mM) has induced a significant increase in whole cell K+ current flowed through KATP channels [see also 4,5], but this was more pronounced in cells infected with SUR2A (Fig. 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_162|20123112|27438|Discussion|0:0|However, there is a report suggesting that a lack of SUR2A, but not Kir6.2 [26], generates a cardiac phenotype with increased resistance to ischaemia/reperfusion [27].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_164|20123112|27438|Discussion|0:0|On the other hand, transgenic mice with moderately increased expression of SUR2A also acquire resistance to metabolic stress, which was explained by increase in numbers of sarcolemmal KATP channels and earlier channel activation in response to metabolic stress [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_190|20123112|31877|Discussion|0:0|It has been demonstrated, at the both recombinant and native levels, that M-LDH physically associated with KATP channels is required, by virtue of its catalytic activity, for the channel opening during metabolic stress [4,5,9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_217|20123112|37169|Discussion|0:0|Chronic mild hypoxia protects heart-derived H9c2 cells against acute hypoxia/reoxygenation by regulating expression of the SUR2A subunit of the ATP-sensitive K+ channels|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_13|20123112|1336|Introduction|0:0|The mechanism of SUR2A-mediated cardioprotection seems to be associated with increased numbers of sarcolemmal KATP channels, earlier activation of KATP channels during stress, shortening of the action membrane potential and consequent decrease in Ca2+ influx [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_20|20123112|2857|Introduction|0:0|Here, we have generated adenovirus containing gene encoding SUR2A and tested the effect that this construct has on survival of H9C2 cells exposed to severe metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_149|20123112|25725|Discussion|0:0|It should be mentioned that a transgenic phenotype overexpressing SUR2A by action of alphaMHC promoter has decreased the number of sarcolemmal KATP channels [23].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_152|20123112|25725|Discussion|0:0|It has been reported that cardiac Kir6.2 mRNA levels are physiologically ~ 30 times higher than those values of SUR2A [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_161|20123112|27438|Discussion|0:0|An increase in sarcolemmal KATP channels is associated with increased myocardial resistance to metabolic stress [7,8,25].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_174|20123112|28837|Discussion|0:0|Based on these findings, it was concluded that production of ATP by sarcolemmal KATP channel protein complex is a significant part of the mechanism underlying KATP channel-mediated cardioprotection.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_179|20123112|28837|Discussion|0:0|To test hypothesis that production of ATP by glycolytic enzymes physically associated with KATP channel subunits mediates the effect of SUR2A on subsarcolemmal ATP, we have used 2-deoxyglucose, a known inhibitor of glycolysis.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_207|20123112|36288|Discussion|0:0|In conclusion, this study has shown that infection with SUR2A increases resistance to metabolic stress in H9C2 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_225|20123112|38083|Discussion|0:0|Delivery of genes encoding KATP channel subunits in conjunction with pinacidil prevents membrane depolarisation in cells exposed to chemical hypoxia-reoxygenation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_19|20123112|2857|Introduction|0:0|As an example, these cells have been used to uncover the effect of increased SUR2A expression on cellular response to metabolic stress [7,8], which was shown to correspond to adult hearts exposed to hypoxia [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_115|20123112|19637|Results|0:0|Sarcolemmal KATP channel complex seems to contain, besides the channel subunits, glycolytic and other enzymes that catalyses reactions producing ATP [9,12,19-22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_176|20123112|28837|Discussion|0:0|This would support the notion that sarcolemmal KATP channel protein complex produces ATP and that this property could be important even under physiological conditions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_191|20123112|31877|Discussion|0:0|It has been suggested that M-LDH-produced lactate 1) targets and activates KATP channels and 2) decreases the channel sensitivity to inhibitory effect of ATP [36,37].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_206|20123112|31877|Discussion|0:0|This is compatible with idea that SUR2A level is the rate limiting factor in regulating numbers of sarcolemmal KATP channels and cell resistance to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_229|20123112|38537|Discussion|0:0|Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_2|20123112|15585|#section_info|0:0|Using this strategy, we measured only those Kir6.2 and SUR2A subunits that physically assemble in sarcolemma to form a channel. Western blot has demonstrated that the level of myocardial SUR2A protein was increased in H9C2 cells in comparison to control cells (Fig. 1). |#main_body|GO:0017098|sulfonylurea receptor binding|#go_definition|IPI|GOA|Kcnj8(25472)|#gene_synonym
0.75	20123112_187|20123112|31877|Discussion|0:0|It has been shown that M-LDH, but not H-LDH, physically associates with Kir6.2 and SUR2A subunits and is integral part of the sarcolemmal KATP channel protein complex [9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	20123112_145|20123112|25725|Discussion|0:0|It has been previously shown that moderate increase in SUR2A generates a myocardial phenotype with increased numbers of sarcolemmal KATP channels and increased resistance to ischaemia-reperfusion [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.7	20123112_160|20123112|27438|Discussion|0:0|The finding that DNP-induced K+ current was increased in cells infected with SUR2A is in accord with these cells having increased number of sarcolemmal KATP channels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	20123112_4|20123112|158|abstract|0:0|Adenoviral SUR2A construct (AV-SUR2A) increased SUR2A expression, number of KATP channels and subsarcolemmal ATP in glycolysis-sensitive manner in H9C2 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	20123112_97|20123112|15521|Results|0:0|Infection with SUR2A increases the level of SUR2A in H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	20123112_18|20123112|2857|Introduction|0:0|It has been shown that rat heart embryonic H9C2 cells are good experimental model to study SUR2A, KATP channels and cardioprotection [6].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_114|20123112|19563|Results|0:0|Infection with SUR2A increases levels of subsarcolemmal ATP in H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_122|20123112|20996|Results|0:0|An increased ATP levels in subsarcolemmal space would be in accord with the idea that enzymes physically associated with the KATP channel subunits produce ATP and that infection with SUR2A increases number of ATP-producing KATP channel protein complexes [4,5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_133|20123112|23276|Results|0:0|We have recently shown that 193glyM-LDH, a mutant form of muscle lactate dehydrogenase (M-LDH) that has lost its catalytic activity while retained the ability to physically interact with Kir6.2/SUR2A, inhibits both DNP-induced KATP channel activation and ATP production by sarcolemmal KATP channels [4].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_144|20123112|25530|Discussion|0:0|In the present study we have shown that SUR2A mediate cardioprotection by increasing the numbers of sarcolemmal KATP channels and consequent increase in K+ current and subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_170|20123112|28837|Discussion|0:0|However, it has been shown that the activation of KATP channels is protective in cells that do not generate action membrane potential, including diastolic cardiomyocytes [14-16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_177|20123112|28837|Discussion|0:0|The structural studies of KATP channels have shown that channel subunits in vivo are physically associated with enzymes that catalyses ATP production, most of them being involved in glycolysis [9,12,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_8|20123112|158|abstract|0:0|We conclude that AV-SUR2A increases resistance to metabolic stress in H9C2 cells by increasing the number of sarcolemmal KATP channels and subsarcolemmal ATP.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_11|20123112|1336|Introduction|0:0|Structurally, sarcolemmal KATP channels in vivo are composed of an inward rectifier, Kir6.2 and Kir6.1, SUR2A, an ATP-binding protein, and accessory proteins that are glycolytic and ATP-producing enzymes [reviewed in 1].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_12|20123112|1336|Introduction|0:0|Recently, it has been shown that cardiomyocytes from transgenic mice overexpressing KATP channel regulatory subunit, SUR2A, acquire resistance against hypoxia and other types of metabolic stresses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_147|20123112|25725|Discussion|0:0|Under CMV promoter SUR2A mRNA in hearts of transgenic animals was increased for ~ 6 times in comparison to the wild type [2], which is similar to those in H9C2 cells achieved by AV-SUR2A.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_172|20123112|28837|Discussion|0:0|Specifically, it has been found that inhibition of the catalytic activity of M-LDH, an enzyme physically associated with sarcolemmal KATP channels [9], results in decreased ATP levels as well as inhibited KATP channels-mediated K+ current in response to stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_203|20123112|31877|Discussion|0:0|The fact that 193glyM-LDH was more efficient in inhibiting SUR2A than Kir6.2AFA supports our hypothesis that infection of H9C2 cells with AV-SUR2A led to increased numbers of sarcolemmal KATP channels, increase in subsarcolemmal ATP and increased K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20123112_165|20123112|27438|Discussion|0:0|Here, we have shown that an acute increase in SUR2A expression confers cytoprotection, which would be in accord with reports associating increased SUR2A with the cardioprotective outcome [29].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20123112_208|20123112|36288|Discussion|0:0|The mechanism underlying SUR2A-mediated cytoprotection is associated with increase in number of sarcolemmal KATP channels, increased K+ current as well as increased production of ATP by the glycolytic enzymes physically associated with KATP channel subunits.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_148|20123112|25725|Discussion|0:0|This modest up-regulation of SUR2A has resulted in increased number of sarcolemmal KATP channels, which is in accord to what has been observed in transgenic CMV-SUR2A phenotype [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_181|20123112|28837|Discussion|0:0|This would be in agreement with the idea that ATP produced by glycolytic enzymes physically associated with KATP channel subunits underlies SUR2A-mediated increase in subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_195|20123112|31877|Discussion|0:0|This finding is in accord with our hypothesis that infection with AV-SUR2A has increased the number of sarcolemmal KATP channel protein complexes that are both important for subsarcolemmal ATP levels and K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_197|20123112|31877|Discussion|0:0|However, it is known that ischaemia opens sarcolemmal KATP channels before the fall of intracellular ATP occur [38], suggesting that the intracellular level of ATP is not the only factor that regulates the channel activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_214|20123112|36946|Discussion|0:0|M-LDH physically associated with sarcolemmal KATP channels mediates cytoprotection in heart embryonic H9C2 cells|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_15|20123112|1336|Introduction|0:0|More specifically, it has been suggested that enzymes that are physically associated with KATP channel subunits regulate subsarcolemmal/intracellular ATP levels, which, in turn, promotes cellular survival under metabolic stress [3-5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_26|20123112|3734|Methods|0:0|For the experiments H9C2 cells were infected with adenoviral constructs containing either green fluorescent protein (GFP, gift from C. Sunderland, University of Dundee; cells infected with GFP have served as control cells in this study), gly193-M-LDH (a catalytically inactive mutant of M-LDH, [9], Kir6.2, or Kir6.2AFA (a mutant form of Kir6.2 where the pore GFG was mutated into AFA leading to largely reduced K+ conductance, [10]).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_103|20123112|16656|Results|0:0|In control cells, exposure to DNP (10 mM) has induced a significant increase in whole cell K+ current flowed through KATP channels [see also 4,5], but this was more pronounced in cells infected with SUR2A (Fig. 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_162|20123112|27438|Discussion|0:0|However, there is a report suggesting that a lack of SUR2A, but not Kir6.2 [26], generates a cardiac phenotype with increased resistance to ischaemia/reperfusion [27].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_164|20123112|27438|Discussion|0:0|On the other hand, transgenic mice with moderately increased expression of SUR2A also acquire resistance to metabolic stress, which was explained by increase in numbers of sarcolemmal KATP channels and earlier channel activation in response to metabolic stress [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_190|20123112|31877|Discussion|0:0|It has been demonstrated, at the both recombinant and native levels, that M-LDH physically associated with KATP channels is required, by virtue of its catalytic activity, for the channel opening during metabolic stress [4,5,9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_217|20123112|37169|Discussion|0:0|Chronic mild hypoxia protects heart-derived H9c2 cells against acute hypoxia/reoxygenation by regulating expression of the SUR2A subunit of the ATP-sensitive K+ channels|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_13|20123112|1336|Introduction|0:0|The mechanism of SUR2A-mediated cardioprotection seems to be associated with increased numbers of sarcolemmal KATP channels, earlier activation of KATP channels during stress, shortening of the action membrane potential and consequent decrease in Ca2+ influx [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_20|20123112|2857|Introduction|0:0|Here, we have generated adenovirus containing gene encoding SUR2A and tested the effect that this construct has on survival of H9C2 cells exposed to severe metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_149|20123112|25725|Discussion|0:0|It should be mentioned that a transgenic phenotype overexpressing SUR2A by action of alphaMHC promoter has decreased the number of sarcolemmal KATP channels [23].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_152|20123112|25725|Discussion|0:0|It has been reported that cardiac Kir6.2 mRNA levels are physiologically ~ 30 times higher than those values of SUR2A [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_161|20123112|27438|Discussion|0:0|An increase in sarcolemmal KATP channels is associated with increased myocardial resistance to metabolic stress [7,8,25].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_174|20123112|28837|Discussion|0:0|Based on these findings, it was concluded that production of ATP by sarcolemmal KATP channel protein complex is a significant part of the mechanism underlying KATP channel-mediated cardioprotection.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_179|20123112|28837|Discussion|0:0|To test hypothesis that production of ATP by glycolytic enzymes physically associated with KATP channel subunits mediates the effect of SUR2A on subsarcolemmal ATP, we have used 2-deoxyglucose, a known inhibitor of glycolysis.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_207|20123112|36288|Discussion|0:0|In conclusion, this study has shown that infection with SUR2A increases resistance to metabolic stress in H9C2 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_225|20123112|38083|Discussion|0:0|Delivery of genes encoding KATP channel subunits in conjunction with pinacidil prevents membrane depolarisation in cells exposed to chemical hypoxia-reoxygenation|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_19|20123112|2857|Introduction|0:0|As an example, these cells have been used to uncover the effect of increased SUR2A expression on cellular response to metabolic stress [7,8], which was shown to correspond to adult hearts exposed to hypoxia [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_115|20123112|19637|Results|0:0|Sarcolemmal KATP channel complex seems to contain, besides the channel subunits, glycolytic and other enzymes that catalyses reactions producing ATP [9,12,19-22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_176|20123112|28837|Discussion|0:0|This would support the notion that sarcolemmal KATP channel protein complex produces ATP and that this property could be important even under physiological conditions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_191|20123112|31877|Discussion|0:0|It has been suggested that M-LDH-produced lactate 1) targets and activates KATP channels and 2) decreases the channel sensitivity to inhibitory effect of ATP [36,37].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_206|20123112|31877|Discussion|0:0|This is compatible with idea that SUR2A level is the rate limiting factor in regulating numbers of sarcolemmal KATP channels and cell resistance to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_229|20123112|38537|Discussion|0:0|Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_3|20123112|15585|#section_info|0:0|Furthermore, we have probed anti-Kir6.2 immunoprecipitate of H9C2 extract with anti-SUR2 antibody. Using this strategy, we measured only those Kir6.2 and SUR2A subunits that physically assemble in sarcolemma to form a channel.|#main_body|GO:0005515|protein binding|#go_definition|IDA|GOA|Kir6.2(83535)|#gene_synonym
0.7	20123112_187|20123112|31877|Discussion|0:0|It has been shown that M-LDH, but not H-LDH, physically associates with Kir6.2 and SUR2A subunits and is integral part of the sarcolemmal KATP channel protein complex [9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_177|20123112|28837|Discussion|0:0|The structural studies of KATP channels have shown that channel subunits in vivo are physically associated with enzymes that catalyses ATP production, most of them being involved in glycolysis [9,12,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_133|20123112|23276|Results|0:0|We have recently shown that 193glyM-LDH, a mutant form of muscle lactate dehydrogenase (M-LDH) that has lost its catalytic activity while retained the ability to physically interact with Kir6.2/SUR2A, inhibits both DNP-induced KATP channel activation and ATP production by sarcolemmal KATP channels [4].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_4|20123112|15585|#section_info|0:0|Furthermore, we have probed anti-Kir6.2 immunoprecipitate of H9C2 extract with anti-SUR2 antibody. Using this strategy, we measured only those Kir6.2 and SUR2A subunits that physically assemble in sarcolemma to form a channel.|#main_body|GO:0005515|protein binding|#go_definition|IDA|GOA|Kcnj11(83535)|#gene_synonym
0.7	20123112_187|20123112|31877|Discussion|0:0|It has been shown that M-LDH, but not H-LDH, physically associates with Kir6.2 and SUR2A subunits and is integral part of the sarcolemmal KATP channel protein complex [9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_177|20123112|28837|Discussion|0:0|The structural studies of KATP channels have shown that channel subunits in vivo are physically associated with enzymes that catalyses ATP production, most of them being involved in glycolysis [9,12,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_133|20123112|23276|Results|0:0|We have recently shown that 193glyM-LDH, a mutant form of muscle lactate dehydrogenase (M-LDH) that has lost its catalytic activity while retained the ability to physically interact with Kir6.2/SUR2A, inhibits both DNP-induced KATP channel activation and ATP production by sarcolemmal KATP channels [4].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_5|20123112|15585|#section_info|0:0|Another protein known to be a part of the sarcolemmal KATP channel protein complex, GAPDH [12], was also increased in cell infected with SUR2A (Fig. 1).|#main_body|GO:0019899|enzyme binding|#go_definition|IPI|GOA|Kcnj8(25472)|#gene_synonym
0.73	20123112_123|20123112|20996|Results|0:0|So far, five glycolytic enzymes were identified as parts of sarcolemmal KATP channel protein complex [9,10,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.73	20123112_187|20123112|31877|Discussion|0:0|It has been shown that M-LDH, but not H-LDH, physically associates with Kir6.2 and SUR2A subunits and is integral part of the sarcolemmal KATP channel protein complex [9].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	20123112_174|20123112|28837|Discussion|0:0|Based on these findings, it was concluded that production of ATP by sarcolemmal KATP channel protein complex is a significant part of the mechanism underlying KATP channel-mediated cardioprotection.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	20123112_160|20123112|27438|Discussion|0:0|The finding that DNP-induced K+ current was increased in cells infected with SUR2A is in accord with these cells having increased number of sarcolemmal KATP channels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	20123112_208|20123112|36288|Discussion|0:0|The mechanism underlying SUR2A-mediated cytoprotection is associated with increase in number of sarcolemmal KATP channels, increased K+ current as well as increased production of ATP by the glycolytic enzymes physically associated with KATP channel subunits.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_11|20123112|1336|Introduction|0:0|Structurally, sarcolemmal KATP channels in vivo are composed of an inward rectifier, Kir6.2 and Kir6.1, SUR2A, an ATP-binding protein, and accessory proteins that are glycolytic and ATP-producing enzymes [reviewed in 1].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_122|20123112|20996|Results|0:0|An increased ATP levels in subsarcolemmal space would be in accord with the idea that enzymes physically associated with the KATP channel subunits produce ATP and that infection with SUR2A increases number of ATP-producing KATP channel protein complexes [4,5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_177|20123112|28837|Discussion|0:0|The structural studies of KATP channels have shown that channel subunits in vivo are physically associated with enzymes that catalyses ATP production, most of them being involved in glycolysis [9,12,22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	20123112_195|20123112|31877|Discussion|0:0|This finding is in accord with our hypothesis that infection with AV-SUR2A has increased the number of sarcolemmal KATP channel protein complexes that are both important for subsarcolemmal ATP levels and K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	20123112_172|20123112|28837|Discussion|0:0|Specifically, it has been found that inhibition of the catalytic activity of M-LDH, an enzyme physically associated with sarcolemmal KATP channels [9], results in decreased ATP levels as well as inhibited KATP channels-mediated K+ current in response to stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	20123112_221|20123112|37594|Discussion|0:0|Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal KATP channel|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_15|20123112|1336|Introduction|0:0|More specifically, it has been suggested that enzymes that are physically associated with KATP channel subunits regulate subsarcolemmal/intracellular ATP levels, which, in turn, promotes cellular survival under metabolic stress [3-5].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	20123112_145|20123112|25725|Discussion|0:0|It has been previously shown that moderate increase in SUR2A generates a myocardial phenotype with increased numbers of sarcolemmal KATP channels and increased resistance to ischaemia-reperfusion [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_103|20123112|16656|Results|0:0|In control cells, exposure to DNP (10 mM) has induced a significant increase in whole cell K+ current flowed through KATP channels [see also 4,5], but this was more pronounced in cells infected with SUR2A (Fig. 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_115|20123112|19637|Results|0:0|Sarcolemmal KATP channel complex seems to contain, besides the channel subunits, glycolytic and other enzymes that catalyses reactions producing ATP [9,12,19-22].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_176|20123112|28837|Discussion|0:0|This would support the notion that sarcolemmal KATP channel protein complex produces ATP and that this property could be important even under physiological conditions.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_181|20123112|28837|Discussion|0:0|This would be in agreement with the idea that ATP produced by glycolytic enzymes physically associated with KATP channel subunits underlies SUR2A-mediated increase in subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_188|20123112|31877|Discussion|0:0|DNP is a known inhibitor of oxidative phosphorylation, but the mechanism of DNP-induced activation of sarcolemmal KATP channels is less associated with decrease of intracellular ATP and more with increase in intracellular lactate levels and acidification [32-35].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_197|20123112|31877|Discussion|0:0|However, it is known that ischaemia opens sarcolemmal KATP channels before the fall of intracellular ATP occur [38], suggesting that the intracellular level of ATP is not the only factor that regulates the channel activity.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_203|20123112|31877|Discussion|0:0|The fact that 193glyM-LDH was more efficient in inhibiting SUR2A than Kir6.2AFA supports our hypothesis that infection of H9C2 cells with AV-SUR2A led to increased numbers of sarcolemmal KATP channels, increase in subsarcolemmal ATP and increased K+ current in response to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_206|20123112|31877|Discussion|0:0|This is compatible with idea that SUR2A level is the rate limiting factor in regulating numbers of sarcolemmal KATP channels and cell resistance to metabolic stress.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_12|20123112|1336|Introduction|0:0|Recently, it has been shown that cardiomyocytes from transgenic mice overexpressing KATP channel regulatory subunit, SUR2A, acquire resistance against hypoxia and other types of metabolic stresses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_18|20123112|2857|Introduction|0:0|It has been shown that rat heart embryonic H9C2 cells are good experimental model to study SUR2A, KATP channels and cardioprotection [6].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_133|20123112|23276|Results|0:0|We have recently shown that 193glyM-LDH, a mutant form of muscle lactate dehydrogenase (M-LDH) that has lost its catalytic activity while retained the ability to physically interact with Kir6.2/SUR2A, inhibits both DNP-induced KATP channel activation and ATP production by sarcolemmal KATP channels [4].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_148|20123112|25725|Discussion|0:0|This modest up-regulation of SUR2A has resulted in increased number of sarcolemmal KATP channels, which is in accord to what has been observed in transgenic CMV-SUR2A phenotype [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_161|20123112|27438|Discussion|0:0|An increase in sarcolemmal KATP channels is associated with increased myocardial resistance to metabolic stress [7,8,25].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_179|20123112|28837|Discussion|0:0|To test hypothesis that production of ATP by glycolytic enzymes physically associated with KATP channel subunits mediates the effect of SUR2A on subsarcolemmal ATP, we have used 2-deoxyglucose, a known inhibitor of glycolysis.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_198|20123112|31877|Discussion|0:0|In addition to ATP, it has been suggested that the activity of these channels may be regulated by other nucleotides, intracellular pH, lactate, cytoskeleton, protein kinase C, phosphatidylinositol-4,5-bisphosphate, and by the operative condition of the channel itself [39].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_218|20123112|37339|Discussion|0:0|M-LDH serves as a sarcolemmal KATP channel subunit essential for cell protection against ischemia|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_13|20123112|1336|Introduction|0:0|The mechanism of SUR2A-mediated cardioprotection seems to be associated with increased numbers of sarcolemmal KATP channels, earlier activation of KATP channels during stress, shortening of the action membrane potential and consequent decrease in Ca2+ influx [2].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_129|20123112|22106|Results|0:0|When Kir6.2AFA cells were infected with SUR2A no changes in intracellular ATP was observed (the intensity of luminescence was 494.0 +- 31.2 AU in Kir6.2AFA and 493.6 +- 59.7 AU in Kir6.2AFA/SUR2A cells, n = 5, P = 0.99, Fig. 7).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_131|20123112|22106|Results|0:0|7), as opposed to the level of subsarcolemmal ATP that was significantly increased in cells infected with SUR2A (the intensity of luminescence was 114.3 +- 6.5 AU in Kir6.2AFA and 204.0 +- 7.6 AU in Kir6.2AFA/SUR2A cells, n = 5, P < 0.001, Fig. 7).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_144|20123112|25530|Discussion|0:0|In the present study we have shown that SUR2A mediate cardioprotection by increasing the numbers of sarcolemmal KATP channels and consequent increase in K+ current and subsarcolemmal ATP levels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_170|20123112|28837|Discussion|0:0|However, it has been shown that the activation of KATP channels is protective in cells that do not generate action membrane potential, including diastolic cardiomyocytes [14-16].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_178|20123112|28837|Discussion|0:0|Such composition of sarcolemmal KATP channels would allow a supposition that KATP channel protein complex could serve as ATP-producing machinery in the sarcolemma.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_191|20123112|31877|Discussion|0:0|It has been suggested that M-LDH-produced lactate 1) targets and activates KATP channels and 2) decreases the channel sensitivity to inhibitory effect of ATP [36,37].|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_205|20123112|31877|Discussion|0:0|It is also worthwhile mentioning that cell survival after concomitant infection with SUR2A and Kir6.2 was not statistically different from those in cells infected with SUR2A alone.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_6|20123112|18501|#section_info|0:0|When Kir6.2AFA is introduced into H9C2 cells DNP does not induce increase in K+ current,|#main_body|GO:1901381|positive regulation of potassium ion transmembrane transport|#go_definition|IMP|GOA|Kcnj8(25472)|#gene_synonym
0.63	20123112_160|20123112|27438|Discussion|0:0|The finding that DNP-induced K+ current was increased in cells infected with SUR2A is in accord with these cells having increased number of sarcolemmal KATP channels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_255|20123112|41255|Discussion|0:0|Original membrane currents under depicted conditions (DNP concentration was 10 mM) and line-scatter graph showing DNP-induced K+ current component (obtained by substraction of whole cell K+ current in the presence and absence of DNP) in control cells (control) and cells infected with AV-SUR2A (SUR2A).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_262|20123112|41978|Discussion|0:0|Original membrane currents under depicted conditions (DNP concentration was 10 mM) and line-scatter graph showing DNP-induced K+ current component (obtained by substraction of whole cell K+ current in the presence and absence of DNP) in cells infected with AV-SUR2A (SUR2A) and AV-SUR2A plus AV-Kir6.2AFA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_103|20123112|16656|Results|0:0|In control cells, exposure to DNP (10 mM) has induced a significant increase in whole cell K+ current flowed through KATP channels [see also 4,5], but this was more pronounced in cells infected with SUR2A (Fig. 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
20123112_7|20123112|18501|#section_info|0:0|When Kir6.2AFA is introduced into H9C2 cells DNP does not induce increase in K+ current,|#main_body|GO:1901381|positive regulation of potassium ion transmembrane transport|#go_definition|IMP|GOA|Kcnj8(25472)|#gene_synonym
0.63	20123112_160|20123112|27438|Discussion|0:0|The finding that DNP-induced K+ current was increased in cells infected with SUR2A is in accord with these cells having increased number of sarcolemmal KATP channels.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	20123112_255|20123112|41255|Discussion|0:0|Original membrane currents under depicted conditions (DNP concentration was 10 mM) and line-scatter graph showing DNP-induced K+ current component (obtained by substraction of whole cell K+ current in the presence and absence of DNP) in control cells (control) and cells infected with AV-SUR2A (SUR2A).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	20123112_262|20123112|41978|Discussion|0:0|Original membrane currents under depicted conditions (DNP concentration was 10 mM) and line-scatter graph showing DNP-induced K+ current component (obtained by substraction of whole cell K+ current in the presence and absence of DNP) in cells infected with AV-SUR2A (SUR2A) and AV-SUR2A plus AV-Kir6.2AFA.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	20123112_103|20123112|16656|Results|0:0|In control cells, exposure to DNP (10 mM) has induced a significant increase in whole cell K+ current flowed through KATP channels [see also 4,5], but this was more pronounced in cells infected with SUR2A (Fig. 2).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
